- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 279/04 - Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
Patent holdings for IPC class C07C 279/04
Total number of patents in this class: 80
10-year publication summary
12
|
9
|
8
|
3
|
5
|
6
|
3
|
0
|
6
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Immunomet Therapeutics Inc. | 29 |
6 |
Monsanto Technology LLC | 8071 |
4 |
Emory University | 1591 |
4 |
Ramot at Tel-Aviv University Ltd. | 1452 |
4 |
BASF SE | 20519 |
3 |
Sika Technology AG | 2862 |
3 |
3m Innovative Properties Company | 17998 |
2 |
Flamel Technologies | 38 |
2 |
King Abdulaziz University | 505 |
2 |
Lantheus Medical Imaging, Inc. | 172 |
2 |
The Penn State Research Foundation | 1468 |
2 |
Philipps-universitat Marburg | 108 |
2 |
San-Apro Limited | 77 |
2 |
Sanford-Burnham Medical Research Institute | 128 |
2 |
Waters Technologies Corporation | 1684 |
2 |
Murata Manufacturing Co., Ltd. | 23844 |
1 |
The Regents of the University of Michigan | 4596 |
1 |
The Johns Hopkins University | 5554 |
1 |
The General Hospital Corporation | 4659 |
1 |
Tsinghua University | 5731 |
1 |
Other owners | 33 |